1351763-65-9

Upstream product

• 169504-53-4 1-(4-ethoxy-benzyl)-3,4-dihydro-1H-benzo[e][1,4]diazepine-2,5-dione 
• 1251927-29-3 methyl 5-chloro-2-(3-cyanopropoxy)benzoate 
• 1271524-67-4 3-amino-5-(2,4,6-trichloro-phenyl)-1,3-dihydro-benzo[e][1,4]diazepin-2-one hydrochloride 
• 1351763-22-8 2-(3-(2H-tetrazol-5-yl)propoxy)-5-chlorobenzoic acid 
• 5363-29-1 2-(4-methoxybenzylamino)benzoic acid 
• 1271523-27-3 [1-(4-methoxy-benzyl)-2-oxo-5-(2,4,6-trichloro-phenyl)-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]-carbamic acid tert-butyl ester 
• 376584-36-0 [5-chloro-1-(4-methoxy-benzyl)-2-oxo-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl]-carbamic acid tert-butyl ester 
• 376584-35-9 3-azido-5-chloro-1-(4-methoxy-benzyl)-1,3-dihydro-benzo[e][1,4]diazepin-2-one 
• 376584-34-8 2H-1,4-benzodiazepin-2-one, 5-chloro-1,3-dihydro-1-(4-methoxybenzyl)- 
• 16512-74-6 1-(4-methoxybenzyl)-2H-benzo[d][1,3]oxazine-2,4(1H)-dione 
• 321-14-2 5-chloro-2-hydroxybenzoic acid 
• 4068-78-4 methyl 5-chloro-2-hydroxybenzoate 
• 118-92-3 anthranilic acid 

Relevant academic research and scientific papers

BENZODIAZEPINE COMPOUNDS USEFUL FOR THE TREATMENT OF HEPATITIS C

The invention concerns benzodiazepine derivatives of Formula (I) wherein A, X, L1, L2, R1, R2, R3, R4, R5, R6 and R7 are as defined in the description. The present invention also relates to processes for the preparation of such compounds, pharmaceutical compositions containing them and their use in the treatment or prophylaxis of hepatitis C virus infection.